A citation-based method for searching scientific literature




Lærke S Gasbjerg, Mads M Helsted, Bolette Hartmann, Mette H Jensen, Maria B N Gabe, Alexander H Sparre-Ulrich, Simon Veedfald, Signe Stensen, Amalie R Lanng, Natasha C Bergmann, Mikkel B Christensen, Tina Vilsbøll, Jens J Holst, Mette M Rosenkilde, Filip K Knop. Diabetes 2019
Times Cited: 73




List of shared articles



Times cited

The Location of Missense Variants in the Human GIP Gene Is Indicative for Natural Selection.
Peter Lindquist, Lærke Smidt Gasbjerg, Jacek Mokrosinski, Jens Juul Holst, Alexander Sebastian Hauser, Mette Marie Rosenkilde. Front Endocrinol (Lausanne) 2022
0

Tirzepatide for the treatment of adults with type 2 diabetes: An endocrine perspective.
Christophe De Block, Clifford Bailey, Carol Wysham, Andrea Hemmingway, Sheryl Elaine Allen, Jennifer Peleshok. Diabetes Obes Metab 2022
0


An overview of obesity mechanisms in humans: Endocrine regulation of food intake, eating behaviour and common determinants of body weight.
Simone Theilade, Mikkel B Christensen, Tina Vilsbøll, Filip K Knop. Diabetes Obes Metab 2021
4

GIPR Function in the Central Nervous System: Implications and Novel Perspectives for GIP-Based Therapies in Treating Metabolic Disorders.
Ricardo J Samms, Kyle W Sloop, Fiona M Gribble, Frank Reimann, Alice E Adriaenssens. Diabetes 2021
7

The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update.
Michael A Nauck, Daniel R Quast, Jakob Wefers, Andreas F H Pfeiffer. Diabetes Obes Metab 2021
24

GIP's involvement in the pathophysiology of type 2 diabetes.
Mikkel B Christensen, Lærke S Gasbjerg, Sebastian M Heimbürger, Signe Stensen, Tina Vilsbøll, Filip K Knop. Peptides 2020
6

Molecular interactions of full-length and truncated GIP peptides with the GIP receptor - A comprehensive review.
Maria Buur Nordskov Gabe, Wijnand J C van der Velden, Florent Xavier Smit, Lærke Smidt Gasbjerg, Mette Marie Rosenkilde. Peptides 2020
14

How May GIP Enhance the Therapeutic Efficacy of GLP-1?
Ricardo J Samms, Matthew P Coghlan, Kyle W Sloop. Trends Endocrinol Metab 2020
57

GIP(3-30)NH2 - a tool for the study of GIP physiology.
Mads Bank Lynggaard, Lærke Smidt Gasbjerg, Mikkel Bring Christensen, Filip Krag Knop. Curr Opin Pharmacol 2020
2


The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion-A Review.
David S Mathiesen, Jonatan I Bagger, Natasha C Bergmann, Asger Lund, Mikkel B Christensen, Tina Vilsbøll, Filip K Knop. Int J Mol Sci 2019
28

Increased Body Weight and Fat Mass After Subchronic GIP Receptor Antagonist, but Not GLP-2 Receptor Antagonist, Administration in Rats.
Sara Baldassano, Lærke Smidt Gasbjerg, Hüsün Sheyma Kizilkaya, Mette Marie Rosenkilde, Jens Juul Holst, Bolette Hartmann. Front Endocrinol (Lausanne) 2019
16